Tag Archive for: Amgen

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support

/in

Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures The fund has already screened over 300 projects and made several investments into new companies to catalyze transformative innovation in biotechnology PARIS, France – March 18, 2025 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital […]

Read more

Synaffix Enters License Agreement with Amgen to Build Next Generation ADCs

/in

AMSTERDAM, THE NETHERLANDS, 5 January 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), today announced the signing of a licensing agreement with Amgen to develop next generation ADCs. Amgen will gain access to Synaffix’s antibody conjugation technology platforms comprising GlycoConnect™, HydraSpace™ and select […]

Read more